REVOX

Q&A with Mason Schwartz: Technical Learnings about Vaporized Peracetic Acid (VPA)

  • Posted on: 31 July 2017
  • By: REVOX Steriliza...


Inventor of VPA technology and current Director of Research & Development and Operations with REVOX Sterilization Solutions, Mason Schwartz, discusses the science behind VPA.
 

1. The VPA sterilization process has a distinct advantage over many other sterilization solutions because it is executed at room temperature. From a chemistry standpoint, why is this important?

Q & A with Matt Conlon: Sterilization Industry Trends and Opportunities

  • Posted on: 23 March 2017
  • By: REVOX Steriliza...

 

Matt Conlon, V.P. and General Manager of REVOX® Sterilization Solutions, discusses the latest advancements and opportunities in the medical technology and sterilization industries.


What is the leading trend you have seen in the past year in the medical device market?

Introduction to VPA (Vaporized Peracetic Acid) Sterilization; A New Path to Innovation and Efficiency - Webinar

  • Posted on: 13 March 2017
  • By: REVOX Steriliza...
Learn about the benefits of VPA over traditional sterilization methods from the inventor of the VPA technology:
  • Sterilize products without exposing them to high temperatures, moisture, radiation or hazardous chemical by-products
  • Gently sterilize all surfaces of a product within its package, leaving behind no residuals
  • VPA breaks down into relatively harmless, natural occurring substances: water, oxygen and carbon dioxide
  • Safe and easy to install, the VPA system adds efficient in-line sterilization to your manufacturing process

A Texas Expansion Highlights REVOX Sterilization’s Production Flexibility

  • Posted on: 25 April 2016
  • By: REVOX Steriliza...

Medical manufacturers often find the sterilization process to be a big production and logistical challenge. Long lead times, rigid batch amounts, and log-jams at the sterilization contractor can bring production to a halt and leave the customer dissatisfied. So, a sterilization solution that lets manufacturers avoid these problems stands as a big leap forward.

That’s where REVOX® Sterilization Solutions’ unique capabilities come in.

Learn more about VPA (Vaporized Peracetic Acid) from MD&DI

  • Posted on: 5 April 2016
  • By: REVOX Steriliza...


Like all manufacturers, medical device companies are constantly looking for ways to optimize their production efficiency. Because patient safety and FDA compliance are top priorities, effective and dependable sterilization is a crucial part of the manufacturing process. However, many medical device manufacturers currently rely on off-site contract sterilization services that introduce inefficiencies, added costs, and risks into the production cycle.